1. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
   Alberto Muñoz et al, 2022, Nutrients CrossRef
2. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway
   Hong Li et al, 2018, Journal of Hematology & Oncology CrossRef
3. Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide
   Julia Gerstmeier et al, 2021, Cancers CrossRef
4. From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM
   Ilhan Elmaci et al, 2019, Metabolic Brain Disease CrossRef
5. Friend or Foe: Paradoxical Roles of Autophagy in Gliomagenesis
   Don Carlo Ramos Batara et al, 2021, Cells CrossRef
6. Hydrolytic instability and low-loading levels of temozolomide to magnetic PLGA nanoparticles remain challenging against glioblastoma therapy
   Fatih Senturk et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
7. Overview of vitamin D actions in cancer
   Marjolein van Driel et al, 2024, Feldman and Pike's Vitamin D CrossRef
8. Advances in biomedical applications of vitamin D for VDR targeted management of obesity and cancer
   Vivek Kumar Gupta et al, 2024, Biomedicine & Pharmacotherapy CrossRef
9. Effects of vitamin D in the nervous system: Special focus on interaction with steroid hormone signalling and a possible role in the treatment of brain cancer
   Maria Norlin, 2020, Journal of Neuroendocrinology CrossRef
10. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells
    Sanghun Lee et al, 2017, International Journal of Oncology CrossRef
11. Current promising treatment strategy for glioblastoma multiform: A review
    Sanjib Bahadur et al, 2019, Oncology Reviews CrossRef
12. Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy
    Tae Hwang et al, 2019, International Journal of Molecular Medicine CrossRef
13. Vitamin D in autophagy signaling for health and diseases: Insights on potential mechanisms and future perspectives
    Sujit Kumar Bhutia, 2022, The Journal of Nutritional Biochemistry CrossRef
14. Characteristics of sulfasalazine-induced cytotoxicity in C6 rat glioma cells
    Raffaela Silvestre Ignarro et al, 2017, Neuroscience Letters CrossRef
15. Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
    Wei Zhou et al, 2017, Frontiers in Molecular Neuroscience CrossRef
16. Impact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells
    Ozlem Kucukhuseyin et al, 2021, Biotechnology & Biotechnological Equipment CrossRef
17. Potential of naso-brain drug delivery in glioblastoma therapy
    Amarjitsing Rajput et al, 2021, Direct Nose-to-Brain Drug Delivery CrossRef
18. In Vitro and In Vivo Antitumor Activity of Vitamin D3 in Malignant Gliomas: A Systematic Review
    Melika Hajimohammadebrahim-Ketabforoush et al, 2020, International Journal of Cancer Management CrossRef
19. Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells
    María Julia Ferronato et al, 2018, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
20. Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications
    Carmen Sze-Ching Lo et al, 2022, Laboratory Investigation CrossRef
21. Harnessing oxidative stress for anti-glioma therapy
    Robert P. Ostrowski et al, 2022, Neurochemistry International CrossRef
22. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
    Sabine Hombach-Klonisch et al, 2018, Pharmacology & Therapeutics CrossRef
23. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
    Daishi Chen et al, 2017, Oncotarget CrossRef
24. Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era
    Xiaoran Zhang et al, 2021, Cancer Gene Therapy CrossRef
25. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
    Francesco Marampon et al, 2017, Cancer Letters CrossRef
26. LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma
    Xin He et al, 2021, Cellular and Molecular Neurobiology CrossRef
27. Do Anti-Oxidants Vitamin D3, Melatonin, and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?
    Diane McConnell et al, 2018, Medicines CrossRef
28. The impact of vitamin D on cancer: A mini review
    Gerbenn Seraphin et al, 2023, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
29. Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis
    Yi Qin et al, 2024, Cancer Letters CrossRef